Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: Grislee bear who wrote (701)	5/13/1999 8:58:00 AM
From: ogod	Respond to of 2344

could not have said it better myself, however the 95k did consist of 42 lots, strangely for about 40 minutes not stepped ahead of the 8 offer just kept adding to the offer could be arbing

To: Grislee bear who wrote (701)	5/13/1999 9:06:00 AM
From: KLH	Read Replies (2) \| Respond to of 2344

I missed the company name, but on CNBC this am some BIO company got FDA fast track approval for their cancer therapy drug. The Stock closed at about 2 yesterday, and is projected to open at 10 today. Not bad, which brings up a question..... how much room do we have in the business for competitive products? There are a lot of companies out there doing similar R&D to each other on cancer cure or maintenance. Will it result in several products to choose from or will there be few, based on those companies that got a big lead time and thus market acceptance? Karl